(Q86839778)
Statements
Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies (English)
Mark D Minden
Donna E Hogge
Scott J Weir
Jim Kasper
Debra A Webster
Lavonne Patton
Yulia Jitkova
Rose Hurren
Marcela Gronda
Carolyn A Goard
Lian G Rajewski
John L Haslam
Kathleen E Heppert
Kevin Schorno
Hong Chang
Joseph M Brandwein
Andre C Schuh
Karen W L Yee